{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T11:10:07Z","timestamp":1767179407453,"version":"build-2238731810"},"update-to":[{"DOI":"10.1371\/journal.pntd.0013567","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000}}],"reference-count":132,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005688","name":"Gottfried und Julia Bangerter-Rhyner-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004784","name":"Novartis Stiftung\u00c2\u00a0f\u00c3\u00bcr\u00c2\u00a0Medizinisch-Biologische Forschung","doi-asserted-by":"publisher","award":["13A13"],"award-info":[{"award-number":["13A13"]}],"id":[{"id":"10.13039\/501100004784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00c3\u00b6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["320030-125316"],"award-info":[{"award-number":["320030-125316"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1032350"],"award-info":[{"award-number":["OPP1032350"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1043345"],"award-info":[{"award-number":["1043345"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1155075"],"award-info":[{"award-number":["1155075"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00c3\u00b6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["31003A-112196"],"award-info":[{"award-number":["31003A-112196"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["AI063135, AI46919, TW007872"],"award-info":[{"award-number":["AI063135, AI46919, TW007872"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000972","name":"Australian Agency for International Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003747","name":"Department of Health, State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003747","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>\n                    Inoculation with\n                    <jats:italic>\n                      <jats:italic>Plasmodium vivax<\/jats:italic>\n                    <\/jats:italic>\n                    malaria parasites can lead to blood-stage infections from the primary infection and relapses from liver-stage parasites or non-circulating merozoites. Understanding the risk of clinical illness following primary infection and relapse would inform surveillance and intervention strategies, but the probabilities are uncertain in people living in endemic areas. A major difficulty lies in the inability to distinguish primary infections and relapses. In this study, we estimate the probabilities of clinical illness using the different seasonal patterns of primary infection and relapse. Children aged one to three years in Ilaita, Papua New Guinea, were followed up over 16 months for illness (fever with \u2265500 parasites\/\u00b5l) with fortnightly active and passive case detection, and for blood-stage infection every two months. Estimates of the number of primary infections and relapses for each two-month time-period, age-group, village and ITN use category were derived from previous analyses using genotyping data. In this study, we use a Bayesian statistical model to relate the number of observed\n                    <jats:italic>\n                      <jats:italic>P. vivax<\/jats:italic>\n                    <\/jats:italic>\n                    clinical cases in each covariate category to the expected numbers of primary infections and relapses. We include the cumulative number of primary infections experienced since birth as a proxy for acquired immunity. To reflect uncertainty, we use varying assumptions about whether relapses can cause illness in different circumstances. The probability of illness decayed exponentially with increasing cumulative numbers of primary infections experienced. The estimated probability of illness following relapses was lower than that for primary infection, how much lower depended on how they were defined. Later relapses within the same brood tended to have lower probabilities than earlier ones. Varying seasonally, relapses were estimated to contribute half of\n                    <jats:italic>\n                      <jats:italic>P. vivax<\/jats:italic>\n                    <\/jats:italic>\n                    illness in this cohort despite accounting for 80% of the force of blood-stage infection. The results can inform estimates of the burden of\n                    <jats:italic>\n                      <jats:italic>P. vivax<\/jats:italic>\n                    <\/jats:italic>\n                    and provide building blocks for mathematical models for predicting the impact of interventions. Interventions triggered by clinical cases would focus on more recent infections and age-groups with less acquired immunity.\n                  <\/jats:p>","DOI":"10.1371\/journal.pntd.0013567","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T17:34:32Z","timestamp":1759512872000},"page":"e0013567","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["The probability of Plasmodium vivax acute illness following primary infection and relapse in Papua New Guinea"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6027-5645","authenticated-orcid":true,"given":"Amanda","family":"Ross","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian","family":"Koepfli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lincoln","family":"Timinao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diggory","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Th\u00fcring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Loeffel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benson","family":"Kiniboro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Felger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"pntd.0013567.ref001","volume-title":"World Malaria Report 2024 Addressing inequity in the global malaria response","year":"2024"},{"issue":"10195","key":"pntd.0013567.ref002","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0140-6736(19)31096-7","article-title":"Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000-17: a spatial and temporal modelling study","volume":"394","author":"KE Battle","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"pntd.0013567.ref003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003614","article-title":"Global economic costs due to vivax malaria and the potential impact of its radical cure: a modelling study","volume":"18","author":"A Devine","year":"2021","journal-title":"PLoS Med"},{"issue":"6","key":"pntd.0013567.ref004","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.pt.2020.03.009","article-title":"Plasmodium vivax in the era of the shrinking P. falciparum map","volume":"36","author":"RN Price","year":"2020","journal-title":"Trends Parasitol"},{"key":"pntd.0013567.ref005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4269\/ajtmh.16-0141","article-title":"Global epidemiology of Plasmodium vivax","volume":"95","author":"RE Howes","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0013567.ref006","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12936-015-0884-z","article-title":"A systematic review of sub-microscopic Plasmodium vivax infection","volume":"14","author":"CM Moreira","year":"2015","journal-title":"Malar J"},{"issue":"10","key":"pntd.0013567.ref007","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S1473-3099(18)30411-0","article-title":"Assessment of ultra-sensitive malaria diagnosis versus standard molecular diagnostics for malaria elimination: an in-depth molecular community cross-sectional study","volume":"18","author":"NE Hofmann","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"pntd.0013567.ref008","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijpara.2016.10.006","article-title":"Infectivity of symptomatic and asymptomatic Plasmodium vivax infections to a Southeast Asian vector, Anopheles dirus","volume":"47","author":"K Kiattibutr","year":"2017","journal-title":"Int J Parasitol"},{"issue":"12","key":"pntd.0013567.ref009","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/cid\/cix1123","article-title":"The relative contribution of symptomatic and asymptomatic Plasmodium vivax and Plasmodium falciparum infections to the infectious reservoir in a low-endemic setting in Ethiopia","volume":"66","author":"FG Tadesse","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"5","key":"pntd.0013567.ref010","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.pt.2018.02.009","article-title":"Plasmodium gametocytes in field studies: do we measure commitment to transmission or detectability?","volume":"34","author":"C Koepfli","year":"2018","journal-title":"Trends Parasitol"},{"key":"pntd.0013567.ref011","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4269\/ajtmh.2001.64.97","article-title":"The neglected burden of Plasmodium vivax malaria","volume":"64","author":"K Mendis","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0013567.ref012","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/B978-0-12-407826-0.00003-5","article-title":"Natural acquisition of immunity to Plasmodium vivax: epidemiological observations and potential targets","volume":"81","author":"I Mueller","year":"2013","journal-title":"Adv Parasitol"},{"issue":"6","key":"pntd.0013567.ref013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002882","article-title":"A high resolution case study of a patient with recurrent Plasmodium vivax infections shows that relapses were caused by meiotic siblings","volume":"8","author":"AT Bright","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0013567.ref014","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01888-17","article-title":"Genomic analyses reveal the common occurrence and complexity of Plasmodium vivax relapses in Cambodia","volume":"9","author":"J Popovici","year":"2018","journal-title":"mBio"},{"issue":"6","key":"pntd.0013567.ref015","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4269\/ajtmh.2004.70.642","article-title":"A retrospective examination of reinfection of humans with Plasmodium vivax","volume":"70","author":"WE Collins","year":"2004","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"pntd.0013567.ref016","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1645\/0022-3395(2002)088[0521:PVBSD]2.0.CO;2","article-title":"Plasmodium vivax blood-stage dynamics","volume":"88","author":"FE McKenzie","year":"2002","journal-title":"J Parasitol"},{"key":"pntd.0013567.ref017","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/B978-0-12-407826-0.00006-0","article-title":"Malariotherapy- insanity at the service of malariology","volume":"81","author":"G Snounou","year":"2013","journal-title":"Adv Parasitol"},{"issue":"11","key":"pntd.0013567.ref018","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/infdis\/jis580","article-title":"Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age","volume":"206","author":"I Betuela","year":"2012","journal-title":"J Infect Dis"},{"issue":"10","key":"pntd.0013567.ref019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001891","article-title":"Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model","volume":"12","author":"LJ Robinson","year":"2015","journal-title":"PLoS Med"},{"issue":"10","key":"pntd.0013567.ref020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003799","article-title":"The global burden of Plasmodium vivax malaria is obscure and insidious","volume":"18","author":"KE Battle","year":"2021","journal-title":"PLoS Med"},{"issue":"8","key":"pntd.0013567.ref021","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1473-3099(20)30142-0","article-title":"Estimating the hidden magnitude of the malaria community burden","volume":"20","author":"T Ketema","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"pntd.0013567.ref022","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S1473-3099(20)30059-1","article-title":"Association between the proportion of Plasmodium falciparum and Plasmodium vivax infections detected by passive surveillance and the magnitude of the asymptomatic reservoir in the community: a pooled analysis of paired health facility and community data","volume":"20","author":"G Stresman","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"pntd.0013567.ref023","article-title":"Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children","volume":"5","author":"E Lin","year":"2010","journal-title":"PLoS One"},{"key":"pntd.0013567.ref024","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1475-2875-8-158","article-title":"Three different Plasmodium species show similar patterns of clinical tolerance of malaria infection","volume":"8","author":"I M\u00fcller","year":"2009","journal-title":"Malar J"},{"key":"pntd.0013567.ref025","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12936-015-0706-3","article-title":"Defining the relationship between Plasmodium vivax parasite rate and clinical disease","volume":"14","author":"KE Battle","year":"2015","journal-title":"Malar J"},{"key":"pntd.0013567.ref026","first-page":"100169","article-title":"Relative contribution of low-density and asymptomatic infections to Plasmodium vivax transmission in the Amazon: pooled analysis of individual participant data from population-based cross-sectional surveys","volume":"9","author":"MU Ferreira","year":"2022","journal-title":"Lancet Reg Health Am"},{"issue":"3","key":"pntd.0013567.ref027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007377","article-title":"Modelling the epidemiology of residual Plasmodium vivax malaria in a heterogeneous host population: a case study in the Amazon Basin","volume":"16","author":"RM Corder","year":"2020","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"pntd.0013567.ref028","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12936-018-2318-1","article-title":"Plasmodium vivax and Plasmodium falciparum infection dynamics: re-infections, recrudescences and relapses","volume":"17","author":"MT White","year":"2018","journal-title":"Malar J"},{"issue":"1","key":"pntd.0013567.ref029","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1038\/s41467-019-13412-x","article-title":"Resolving the cause of recurrent Plasmodium vivax malaria probabilistically","volume":"10","author":"AR Taylor","year":"2019","journal-title":"Nat Commun"},{"issue":"51","key":"pntd.0013567.ref030","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2401024121","article-title":"Modeling the within-host dynamics of Plasmodium vivax hypnozoite activation: an analysis of the SPf66 vaccine trial","volume":"121","author":"S Mehra","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"pntd.0013567.ref031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004582","article-title":"The incidence and differential seasonal patterns of Plasmodium vivax primary infections and relapses in a cohort of children in Papua New Guinea","volume":"10","author":"A Ross","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"pntd.0013567.ref032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019010","article-title":"How much remains undetected? Probability of molecular detection of human Plasmodia in the field","volume":"6","author":"C Koepfli","year":"2011","journal-title":"PLoS One"},{"issue":"12","key":"pntd.0013567.ref033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001424","article-title":"Multiplicity and diversity of Plasmodium vivax infections in a highly endemic region in Papua New Guinea","volume":"5","author":"C Koepfli","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"pntd.0013567.ref034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002403","article-title":"A high force of Plasmodium vivax blood-stage infection drives the rapid acquisition of immunity in Papua New Guinean children","volume":"7","author":"C Koepfli","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"25","key":"pntd.0013567.ref035","doi-asserted-by":"crossref","first-page":"10030","DOI":"10.1073\/pnas.1200841109","article-title":"Force of infection is key to understanding the epidemiology of Plasmodium falciparum malaria in Papua New Guinean children","volume":"109","author":"I Mueller","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pntd.0013567.ref036","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/1475-2875-8-250","article-title":"Comparison of Plasmodium falciparum allelic frequency distribution in different endemic settings by high-resolution genotyping","volume":"8","author":"S Schoepflin","year":"2009","journal-title":"Malar J"},{"issue":"1","key":"pntd.0013567.ref037","article-title":"Theoretical origin of genetically homologous Plasmodium vivax malarial recurrences","volume":"37","author":"M Markus","year":"2022","journal-title":"S Afr J Infect Dis"},{"issue":"21","key":"pntd.0013567.ref038","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMc2023884","article-title":"Hidden biomass of intact malaria parasites in the human spleen","volume":"384","author":"S Kho","year":"2021","journal-title":"N Engl J Med"},{"issue":"7","key":"pntd.0013567.ref039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010648","article-title":"Hypnozoite depletion in successive Plasmodium vivax relapses","volume":"16","author":"R Noviyanti","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0013567.ref040","unstructured":"OpenMalaria. Available from: https:\/\/github.com\/SwissTPH\/openmalaria\/wiki"},{"key":"pntd.0013567.ref041","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1475-2875-7-12","article-title":"Estimation of heterogeneity in malaria transmission by stochastic modelling of apparent deviations from mass action kinetics","volume":"7","author":"TA Smith","year":"2008","journal-title":"Malar J"},{"issue":"1","key":"pntd.0013567.ref042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001157","article-title":"Ensemble modeling of the likely public health impact of a pre-erythrocytic malaria vaccine","volume":"9","author":"T Smith","year":"2012","journal-title":"PLoS Med"},{"issue":"4","key":"pntd.0013567.ref043","first-page":"381","article-title":"Studies in human malaria. XXX. A summary of 204 sporozoite-induced infections with the Chesson strain of Plasmodium vivax","volume":"9","author":"GR Coatney","year":"1950","journal-title":"J Natl Malar Soc"},{"key":"pntd.0013567.ref044","unstructured":"World Health Organization. WHO child growth standards. Available from: http:\/\/www.who.int\/childgrowth\/standards\/en\/"},{"issue":"17","key":"pntd.0013567.ref045","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM198710223171717","article-title":"Simplified calculation of body-surface area","volume":"317","author":"RD Mosteller","year":"1987","journal-title":"N Engl J Med"},{"key":"pntd.0013567.ref046","volume-title":"Stan modeling language users guide and reference manual 2022","author":"Stan Development Team"},{"key":"pntd.0013567.ref047","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2022"},{"key":"pntd.0013567.ref048","volume-title":"RStan: the R interface to Stan 2022","author":"Stan Development Team"},{"issue":"7","key":"pntd.0013567.ref049","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3201\/eid1907.121674","article-title":"Quantifying effect of geographic location on epidemiology of Plasmodium vivax malaria","volume":"19","author":"AA Lover","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"pntd.0013567.ref050","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1017\/S0031182013002369","article-title":"Re-assessing the relationship between sporozoite dose and incubation period in Plasmodium vivax malaria: a systematic re-analysis","volume":"141","author":"AA Lover","year":"2014","journal-title":"Parasitology"},{"issue":"2","key":"pntd.0013567.ref051","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pt.2016.11.001","article-title":"Plasmodium vivax controlled human malaria infection - progress and prospects","volume":"33","author":"RO Payne","year":"2017","journal-title":"Trends Parasitol"},{"key":"pntd.0013567.ref052","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4269\/ajtmh.2006.75.19","article-title":"A model for natural immunity to asexual blood stages of Plasmodium falciparum malaria in endemic areas","volume":"75","author":"N Maire","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0013567.ref053","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.32625","article-title":"Variation in natural exposure to anopheles mosquitoes and its effects on malaria transmission","volume":"7","author":"WM Guelb\u00e9ogo","year":"2018","journal-title":"Elife"},{"key":"pntd.0013567.ref054","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1475-2875-13-144","article-title":"Geographical variation in Plasmodium vivax relapse","volume":"13","author":"KE Battle","year":"2014","journal-title":"Malar J"},{"issue":"4","key":"pntd.0013567.ref055","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/00034983.1995.11812966","article-title":"The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. II. Mortality and morbidity","volume":"89","author":"B Genton","year":"1995","journal-title":"Ann Trop Med Parasitol"},{"issue":"1","key":"pntd.0013567.ref056","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12936-019-2993-6","article-title":"Repeated mosquito net distributions, improved treatment, and trends in malaria cases in sentinel health facilities in Papua New Guinea","volume":"18","author":"D Rodriguez-Rodriguez","year":"2019","journal-title":"Malar J"},{"issue":"6","key":"pntd.0013567.ref057","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0035-9203(96)90406-X","article-title":"The interaction between Plasmodium falciparum and P. vivax in children on Espiritu Santo island, Vanuatu","volume":"90","author":"K Maitland","year":"1996","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"pntd.0013567.ref058","doi-asserted-by":"crossref","first-page":"997","DOI":"10.4269\/ajtmh.2007.76.997","article-title":"The risk of malarial infections and disease in Papua New Guinean children","volume":"76","author":"P Michon","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0013567.ref059","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.23708","article-title":"The complex relationship of exposure to new Plasmodium infections and incidence of clinical malaria in Papua New Guinea","volume":"6","author":"NE Hofmann","year":"2017","journal-title":"Elife"},{"issue":"3","key":"pntd.0013567.ref060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001195","article-title":"Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trial","volume":"9","author":"N Senn","year":"2012","journal-title":"PLoS Med"},{"issue":"5","key":"pntd.0013567.ref061","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/ije\/27.5.878","article-title":"The effect of distance from home on attendance at a small rural health centre in Papua New Guinea","volume":"27","author":"I M\u00fcller","year":"1998","journal-title":"Int J Epidemiol"},{"issue":"1","key":"pntd.0013567.ref062","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12936-017-1944-3","article-title":"Population-level estimates of the proportion of Plasmodium vivax blood-stage infections attributable to relapses among febrile patients attending Adama Malaria Diagnostic Centre, East Shoa Zone, Oromia, Ethiopia","volume":"16","author":"L Golassa","year":"2017","journal-title":"Malar J"},{"issue":"6","key":"pntd.0013567.ref063","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010541","article-title":"The relative impact of interventions on sympatric Plasmodium vivax and Plasmodium falciparum malaria: a systematic review","volume":"16","author":"M Loeffel","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0013567.ref064","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0035-9203(01)90314-1","article-title":"Associations of peak shifts in age--prevalence for human malarias with bednet coverage","volume":"95","author":"T Smith","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"pntd.0013567.ref065","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s13071-018-2787-7","article-title":"High proportions of asymptomatic and submicroscopic Plasmodium vivax infections in a peri-urban area of low transmission in the Brazilian Amazon","volume":"11","author":"ACG Almeida","year":"2018","journal-title":"Parasit Vectors"},{"issue":"11","key":"pntd.0013567.ref066","first-page":"678","article-title":"Priority setting in HIV, tuberculosis, and malaria - new cost-effectiveness results from WHO-CHOICE","volume":"10","author":"AH Ralaidovy","year":"2021","journal-title":"Int J Health Policy Manag"},{"issue":"8","key":"pntd.0013567.ref067","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11538-022-01036-0","article-title":"A multiscale mathematical model of Plasmodium vivax transmission","volume":"84","author":"MN Anwar","year":"2022","journal-title":"Bull Math Biol"},{"key":"pntd.0013567.ref068","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.04692","article-title":"Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission","volume":"3","author":"MT White","year":"2014","journal-title":"Elife"},{"issue":"1","key":"pntd.0013567.ref069","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1038\/s41467-018-05860-8","article-title":"Mathematical modelling of the impact of expanding levels of malaria control interventions on Plasmodium vivax","volume":"9","author":"MT White","year":"2018","journal-title":"Nat Commun"},{"issue":"3","key":"pntd.0013567.ref070","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12199-010-0184-8","article-title":"Risk analysis of the re-emergence of Plasmodium vivax malaria in Japan using a stochastic transmission model","volume":"16","author":"T Bitoh","year":"2011","journal-title":"Environ Health Prev Med"},{"key":"pntd.0013567.ref071","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jtbi.2012.08.024","article-title":"Modeling Plasmodium vivax: relapses, treatment, seasonality, and G6PD deficiency","volume":"316","author":"F Chamchod","year":"2013","journal-title":"J Theor Biol"},{"issue":"6","key":"pntd.0013567.ref072","first-page":"725","article-title":"A mathematical model for Plasmodium vivax malaria transmission: estimation of the impact of transmission-blocking immunity in an endemic area","volume":"69","author":"AP De Zoysa","year":"1991","journal-title":"Bull WHO"},{"issue":"1","key":"pntd.0013567.ref073","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1383-5769(02)00084-3","article-title":"A mathematical model for the transmission of Plasmodium vivax malaria","volume":"52","author":"H Ishikawa","year":"2003","journal-title":"Parasitol Int"},{"issue":"4","key":"pntd.0013567.ref074","first-page":"702","article-title":"Basic reproduction number for the transmission of Plasmodium vivax malaria","volume":"32","author":"A Kammanee","year":"2001","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"2","key":"pntd.0013567.ref075","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jtbi.2010.06.032","article-title":"The dilution effect of the domestic animal population on the transmission of P. vivax malaria","volume":"266","author":"K Nah","year":"2010","journal-title":"J Theor Biol"},{"key":"pntd.0013567.ref076","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1475-2875-7-147","article-title":"A quantitative risk assessment approach for mosquito-borne diseases: malaria re-emergence in southern France","volume":"7","author":"N Pon\u00e7on","year":"2008","journal-title":"Malar J"},{"issue":"1827","key":"pntd.0013567.ref077","first-page":"20160048","article-title":"Variation in relapse frequency and the transmission potential of Plasmodium vivax malaria","volume":"283","author":"MT White","year":"2016","journal-title":"Proc Biol Sci"},{"issue":"2","key":"pntd.0013567.ref078","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11538-020-00706-1","article-title":"An activation-clearance model for Plasmodium vivax malaria","volume":"82","author":"S Mehra","year":"2020","journal-title":"Bull Math Biol"},{"key":"pntd.0013567.ref079","first-page":"685","article-title":"A mathematical model of transmission of Plasmodium vivax malaria with a constant time delay from infection to infectious","volume":"34","author":"A Kammanee","year":"2003","journal-title":"Commun Korean Math Soc"},{"issue":"6","key":"pntd.0013567.ref080","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11538-023-01153-4","article-title":"Optimal interruption of P. vivax malaria transmission using mass drug administration","volume":"85","author":"MN Anwar","year":"2023","journal-title":"Bull Math Biol"},{"issue":"12","key":"pntd.0013567.ref081","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010990","article-title":"Population heterogeneity in Plasmodium vivax relapse risk","volume":"16","author":"E Stadler","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0013567.ref082","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11538-020-00837-5","article-title":"Antibody dynamics for Plasmodium vivax malaria: a mathematical model","volume":"83","author":"S Mehra","year":"2021","journal-title":"Bull Math Biol"},{"key":"pntd.0013567.ref083","article-title":"Hypnozoite dynamics for Plasmodium vivax malaria: the epidemiological effects of radical cure","volume":"537","author":"S Mehra","year":"2021","journal-title":"J Theor Biol"},{"key":"pntd.0013567.ref084","doi-asserted-by":"crossref","first-page":"100789","DOI":"10.1016\/j.epidem.2024.100789","article-title":"Investigation of P. vivax elimination via mass drug administration: a simulation study","volume":"48","author":"MN Anwar","year":"2024","journal-title":"Epidemics"},{"key":"pntd.0013567.ref085","first-page":"117","article-title":"Mathematical model for the transmission of Plasmodium vivax malaria","volume":"1","author":"P Pongsumpun","year":"2007","journal-title":"Int J Math Mod Meth Appl Sci"},{"key":"pntd.0013567.ref086","first-page":"289349","article-title":"Stability of a mathematical model of malaria transmission with relapse","volume":"2014","author":"H Huo","year":"2014","journal-title":"Abstr Appl Anal"},{"key":"pntd.0013567.ref087","first-page":"30","article-title":"A superinfection model on malaria transmission: analysis on the invasion basic reproductive number","volume":"2021","author":"D Aldila","year":"2021","journal-title":"Commun Math Biol Neurosci"},{"issue":"3","key":"pntd.0013567.ref088","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1140\/epjp\/s13360-022-02510-3","article-title":"Recurrent malaria dynamics: insight from mathematical modelling","volume":"137","author":"SF Abimbade","year":"2022","journal-title":"Eur Phys J Plus"},{"issue":"1","key":"pntd.0013567.ref089","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s43069-023-00197-5","article-title":"Optimal control analysis of a mathematical model for recurrent malaria dynamics","volume":"4","author":"S Olaniyi","year":"2023","journal-title":"Oper Res Forum"},{"issue":"1","key":"pntd.0013567.ref090","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s11135-023-01664-1","article-title":"Efficiency and economic analysis of intervention strategies for recurrent malaria transmission","volume":"58","author":"S Olaniyi","year":"2023","journal-title":"Qual Quant"},{"issue":"1","key":"pntd.0013567.ref091","doi-asserted-by":"crossref","first-page":"31","DOI":"10.34312\/jjbm.v4i1.18754","article-title":"Dynamics system in the SEIR-SI model of the spread of malaria with recurrence","volume":"4","author":"A Ahkrizal","year":"2023","journal-title":"Jambura J Biomath"},{"issue":"1","key":"pntd.0013567.ref092","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12916-021-02214-y","article-title":"The empirical support for the radical cure strategy for eliminating Plasmodium vivax in China","volume":"20","author":"G-J Yang","year":"2022","journal-title":"BMC Med"},{"issue":"1","key":"pntd.0013567.ref093","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00285-024-02166-w","article-title":"A spatial multiscale mathematical model of Plasmodium vivax transmission","volume":"90","author":"S Elgart","year":"2024","journal-title":"J Math Biol"},{"key":"pntd.0013567.ref094","article-title":"Developing an agent-based model for simulating the dynamic spread of Plasmodium vivax malaria: a case study of Sarbaz, Iran","volume":"54","author":"N Gharakhanlou","year":"2019","journal-title":"Ecol Inform"},{"issue":"1","key":"pntd.0013567.ref095","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12936-025-05399-2","article-title":"Does mass chloroquine treatment have any role in the elimination of Plasmodium vivax?","volume":"24","author":"NJ White","year":"2025","journal-title":"Malar J"},{"issue":"1","key":"pntd.0013567.ref096","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12936-024-05063-1","article-title":"Intervention portfolios analysis of Plasmodium vivax control in central China","volume":"23","author":"B Bi","year":"2024","journal-title":"Malar J"},{"key":"pntd.0013567.ref097","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/s12936-015-1030-7","article-title":"A validated agent-based model to study the spatial and temporal heterogeneities of malaria incidence in the rainforest environment","volume":"14","author":"F Pizzitutti","year":"2015","journal-title":"Malar J"},{"issue":"1","key":"pntd.0013567.ref098","first-page":"28","article-title":"Mathematical modelling of the dynamics of infectious disease with relapse","volume":"27","author":"H Nyaberi","year":"2020","journal-title":"Asian J Math Comp Res"},{"key":"pntd.0013567.ref099","doi-asserted-by":"crossref","first-page":"125044","DOI":"10.1016\/j.amc.2020.125044","article-title":"Mathematical analysis of reinfection and relapse in malaria dynamics","volume":"373","author":"M Ghosh","year":"2020","journal-title":"Appl Math Comp"},{"key":"pntd.0013567.ref100","doi-asserted-by":"crossref","first-page":"020002","DOI":"10.1063\/5.0023508","article-title":"Modelling malaria transmission in a population with SEIRS method","volume":"2264","author":"M Baihaqi","year":"2020","journal-title":"AIP Conf Proc"},{"issue":"4","key":"pntd.0013567.ref101","first-page":"1095","article-title":"Modeling and investigating malaria P. Falciparum and P. Vivax infections: application to djibouti data","volume":"9","author":"Y Souleiman","year":"2024","journal-title":"Infect Dis Model"},{"key":"pntd.0013567.ref102","first-page":"1","article-title":"Modeling of re-emerging Plasmodium vivax in the north area of the Republic of Korea based on a mathematical model","volume":"11","author":"K Fujita","year":"2006","journal-title":"J Fac Environ Sci Technol Okayama Univ"},{"issue":"2","key":"pntd.0013567.ref103","article-title":"Modelling the impact of rapid diagnostic tests on Plasmodium vivax malaria in South Korea: a cost-benefit analysis","volume":"6","author":"JH Kim","year":"2021","journal-title":"BMJ Glob Health"},{"issue":"1","key":"pntd.0013567.ref104","article-title":"A mathematical model for assessing the effectiveness of controlling relapse in Plasmodium vivax malaria endemic in the Republic of Korea","volume":"15","author":"S Kim","year":"2020","journal-title":"PLoS One"},{"key":"pntd.0013567.ref105","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s43856-022-00073-z","article-title":"Malaria elimination on Hainan Island despite climate change","volume":"2","author":"H Tian","year":"2022","journal-title":"Commun Med (Lond)"},{"key":"pntd.0013567.ref106","doi-asserted-by":"crossref","first-page":"1423004","DOI":"10.3389\/fpubh.2024.1423004","article-title":"Development of a Plasmodium vivax malaria model for evaluating the effects of control strategies on the malaria burden in Democratic People\u2019s Republic of Korea","volume":"12","author":"H Seong","year":"2024","journal-title":"Front Public Health"},{"issue":"27","key":"pntd.0013567.ref107","article-title":"Cost-benefit analysis of tafenoquine for radical cure of Plasmodium vivax malaria in Korea","volume":"37","author":"J Suh","year":"2022","journal-title":"J Korean Med Sci"},{"key":"pntd.0013567.ref108","first-page":"101123","article-title":"Evaluating the impact of the Malakit intervention on malaria transmission in the Guiana Shield: a mathematical modelling study","volume":"47","author":"Y Lambert","year":"2025","journal-title":"Lancet Reg Health Am"},{"issue":"1","key":"pntd.0013567.ref109","article-title":"The potential elimination of Plasmodium vivax malaria by relapse treatment: insights from a transmission model and surveillance data from NW India","volume":"7","author":"M Roy","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"2036","key":"pntd.0013567.ref110","first-page":"20242061","article-title":"Heterogeneous mosquito exposure increases Plasmodium vivax and Plasmodium falciparum co-infections: a modelling study","volume":"291","author":"M Grim\u00e9e","year":"2024","journal-title":"Proc Biol Sci"},{"key":"pntd.0013567.ref111","doi-asserted-by":"crossref","first-page":"102592","DOI":"10.1016\/j.parint.2022.102592","article-title":"Potential role of vaccines in elimination of Plasmodium vivax","volume":"90","author":"M White","year":"2022","journal-title":"Parasitol Int"},{"issue":"10","key":"pntd.0013567.ref112","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3390\/tropicalmed7100263","article-title":"Assessing the impact of relapse, reinfection and recrudescence on malaria eradication policy: a bifurcation and optimal control analysis","volume":"7","author":"H Tasman","year":"2022","journal-title":"Trop Med Infect Dis"},{"key":"pntd.0013567.ref113","doi-asserted-by":"crossref","first-page":"108750","DOI":"10.1016\/j.mbs.2021.108750","article-title":"Using observed incidence to calibrate the transmission level of a mathematical model for Plasmodium vivax dynamics including case management and importation","volume":"343","author":"C Champagne","year":"2022","journal-title":"Math Biosci"},{"issue":"6","key":"pntd.0013567.ref114","article-title":"Early transmission of sensitive strain slows down emergence of drug resistance in Plasmodium vivax","volume":"16","author":"MJC Ayala","year":"2020","journal-title":"PLoS Comput Biol"},{"key":"pntd.0013567.ref115","doi-asserted-by":"crossref","first-page":"100747","DOI":"10.1016\/j.epidem.2024.100747","article-title":"Quantifying the impact of interventions against Plasmodium vivax: a model for country-specific use","volume":"46","author":"C Champagne","year":"2024","journal-title":"Epidemics"},{"issue":"1","key":"pntd.0013567.ref116","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12918-018-0669-4","article-title":"Plasmodium vivax readiness to transmit: implication for malaria eradication","volume":"13","author":"SR Adapa","year":"2019","journal-title":"BMC Syst Biol"},{"issue":"1","key":"pntd.0013567.ref117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011020","article-title":"Individual variation in Plasmodium vivax malaria risk: are repeatedly infected people just unlucky?","volume":"17","author":"R Corder","year":"2023","journal-title":"PLOS Negl Trop Dis"},{"key":"pntd.0013567.ref118","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12936-015-0580-z","article-title":"A simulation model of the within-host dynamics of Plasmodium vivax infection","volume":"14","author":"DH Kerlin","year":"2015","journal-title":"Malar J"},{"key":"pntd.0013567.ref119","doi-asserted-by":"crossref","first-page":"921715","DOI":"10.1155\/2012\/921715","article-title":"Modeling the effects of relapse in the transmission dynamics of malaria parasites","volume":"2012","author":"R Aguas","year":"2012","journal-title":"J Parasitol Res"},{"key":"pntd.0013567.ref120","doi-asserted-by":"crossref","first-page":"100687","DOI":"10.1016\/j.epidem.2023.100687","article-title":"A model for malaria treatment evaluation in the presence of multiple species","volume":"44","author":"CR Walker","year":"2023","journal-title":"Epidemics"},{"key":"pntd.0013567.ref121","doi-asserted-by":"crossref","first-page":"62","DOI":"10.12688\/wellcomeopenres.14771.2","article-title":"Malaria elimination transmission and costing in the Asia-Pacific: a multi-species dynamic transmission model","volume":"4","author":"SP Silal","year":"2019","journal-title":"Wellcome Open Res"},{"key":"pntd.0013567.ref122","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-022-02285-5","article-title":"Developing sero-diagnostic tests to facilitate Plasmodium vivax serological test-and-treat approaches: modeling the balance between public health impact and overtreatment","volume":"20","author":"T Obadia","year":"2022","journal-title":"BMC Med"},{"issue":"4","key":"pntd.0013567.ref123","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003535","article-title":"Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: a modelling study","volume":"18","author":"N Nekkab","year":"2021","journal-title":"PLoS Med"},{"key":"pntd.0013567.ref124","article-title":"Accelerating towards P. vivax elimination with a novel serological test-and-treat strategy: a modelling case study in Brazil","volume":"22","author":"N Nekkab","year":"2023","journal-title":"Lancet Reg Health Am"},{"issue":"1","key":"pntd.0013567.ref125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004255","article-title":"Tafenoquine following G6PD screening versus primaquine for the treatment of vivax malaria in Brazil: a cost-effectiveness analysis using a transmission model","volume":"21","author":"DJ Price","year":"2024","journal-title":"PLoS Med"},{"issue":"6","key":"pntd.0013567.ref126","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S1473-3099(24)00689-3","article-title":"Quantifying Plasmodium vivax radical cure efficacy: a modelling study integrating clinical trial data and transmission dynamics","volume":"25","author":"C Ciavarella","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"pntd.0013567.ref127","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1186\/s12936-021-04017-1","article-title":"How radical is radical cure? Site-specific biases in clinical trials underestimate the effect of radical cure on Plasmodium vivax hypnozoites","volume":"20","author":"JH Huber","year":"2021","journal-title":"Malar J"},{"key":"pntd.0013567.ref128","doi-asserted-by":"crossref","DOI":"10.1007\/s00285-024-02088-7","article-title":"A hybrid transmission model for Plasmodium vivax accounting for superinfection, immunity and the hypnozoite reservoir","volume":"89","author":"S Mehra","year":"2024","journal-title":"Math Biol"},{"issue":"20","key":"pntd.0013567.ref129","article-title":"A systematic analysis of the human immune response to Plasmodium vivax","volume":"133","author":"FA Bach","year":"2023","journal-title":"J Clin Invest"},{"issue":"5","key":"pntd.0013567.ref130","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.pt.2009.02.003","article-title":"The pathophysiology of vivax malaria","volume":"25","author":"NM Anstey","year":"2009","journal-title":"Trends Parasitol"},{"key":"pntd.0013567.ref131","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/B978-0-12-397900-1.00002-5","article-title":"Relapse","volume":"80","author":"NJ White","year":"2012","journal-title":"Adv Parasitol"},{"issue":"6","key":"pntd.0013567.ref132","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099754","article-title":"Plasmodium vivax sporozoite challenge in malaria-na\u00efve and semi-immune Colombian volunteers","volume":"9","author":"M Ar\u00e9valo-Herrera","year":"2014","journal-title":"PLoS One"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0013567","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013567","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:16:13Z","timestamp":1760033773000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013567"}},"subtitle":[],"editor":[{"given":"Gregory","family":"Deye","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":132,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0013567","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]}}}